FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Potassium Acetate Injection
Status: Currently in Shortage
»Date first posted: 06/10/2019
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition

Expand all

Exela Pharma Sciences, LLC (Reverified 09/16/2024)

Company Contact Information:
828-758-5474

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Injection, 3.93 g/20 mL (NDC 51754-2001-4)	Available

Hospira, Inc., a Pfizer Company (Revised 09/11/2024)

Company Contact Information:
844-646-4398

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Potassium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3294-51)	Limited Availability	Limited Supply Available. Next Delivery: November 2024; Estimated Recovery: December 2024	Other
Potassium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-8183-01)	Unavailable	Next Delivery and Estimated Recovery: September 2024	Other
Potassium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3294-25)	Unavailable	Next Delivery: November 2024; Estimated Recovery: December 2024	Other
Potassium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-8183-25)	Available